| NAME |
GABAPENTIN (GRALISE) 450MG TAB,SA |
| VA GENERIC NAME |
GABAPENTIN |
| DOSAGE FORM |
TAB,SA |
| FDA MED GUIDE |
Gabapentin_(Gralise)_(2023).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
450 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
GABAPENTIN TAB,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2023-05-04 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GABAPENTIN (GRALISE) 450MG SA TAB |
| VA PRODUCT IDENTIFIER |
G0517 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4042209 |
| EFFECTIVE DATE/TIME |
-
- 2023-05-04 00:00:00
- STATUS: ACTIVE
|
